Malady Kyle 4
4 · VERIZON COMMUNICATIONS INC · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
Verizon (VZ) EVP Kyle Malady Receives Phantom Stock Award
What Happened Kyle Malady, EVP and Group CEO — VZ Business, was granted 132.86 phantom shares (derivative award) on 2026-06-17 at an imputed value of $13.08 per share, totaling roughly $1,738. The Form 4 classifies this as an award/grant (code A) and the units are economic equivalents of Verizon common stock rather than actual shares.
Key Details
- Transaction date: 2026-06-17; filing date (Form 4): 2026-06-18 (appears to be filed timely).
- Units granted: 132.86 phantom shares at $13.08 each; total value ≈ $1,738.
- Shares owned after transaction: not specified in the provided filing.
- Footnotes: F1 — phantom shares are cash‑settled and payable under the deferred compensation plan; F2 — includes phantom stock acquired via dividend reinvestment.
- Transaction type: Award/Grant of derivative units (not an open‑market buy or sale).
Context Phantom stock is a deferred‑compensation vehicle that mirrors the economic value of common shares but is settled in cash based on plan rules; it does not transfer voting rights or actual shares. Such awards are routine executive compensation and do not by themselves indicate a buy/sell signal in the market.
Insider Transaction Report
- Award
Phantom Stock (unitized)
[F1][F2]2026-06-17$13.08/sh+132.86$1,738→ 417,410.805 total(indirect: By Deferred Compensation Plan)→ Common Stock (38 underlying)
Footnotes (2)
- [F1]Each share of phantom stock is the economic equivalent of a portion of one share of common stock and is settled in cash. The shares of phantom stock become payable upon events established by the reporting person in accordance with the deferred compensation plan.
- [F2]Includes phantom stock acquired through dividend reinvestment.